These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26626785)

  • 1. Myocardial
    De Rosa A; Pellegrino T; Pappatà S; Pellecchia MT; Peluso S; Saccà F; Barone P; Cuocolo A; De Michele G
    J Nucl Cardiol; 2017 Feb; 24(1):103-107. PubMed ID: 26626785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.
    Valldeoriola F; Gaig C; Muxí A; Navales I; Paredes P; Lomeña F; De la Cerda A; Buongiorno M; Ezquerra M; Santacruz P; Martí MJ; Tolosa E
    J Neurol; 2011 Jun; 258(6):1126-32. PubMed ID: 21221623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
    Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.
    Tijero B; Gabilondo I; Lezcano E; Teran-Villagrá N; Llorens V; Ruiz-Martinez J; Marti-Masso JF; Carmona M; Luquin MR; Berganzo K; Fernandez I; Fernandez M; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2015 Jul; 21(7):717-22. PubMed ID: 25960264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
    Kashihara K; Ohno M; Kawada S; Okumura Y
    J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
    Reinhardt MJ; Jüngling FD; Krause TM; Braune S
    Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
    Ruiz-Martínez J; Gorostidi A; Goyenechea E; Alzualde A; Poza JJ; Rodríguez F; Bergareche A; Moreno F; López de Munain A; Martí Massó JF
    Mov Disord; 2011 Sep; 26(11):2026-31. PubMed ID: 21611983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.
    Tijero B; Gómez Esteban JC; Somme J; Llorens V; Lezcano E; Martinez A; Rodríguez T; Berganzo K; Zarranz JJ
    Parkinsonism Relat Disord; 2013 Oct; 19(10):906-9. PubMed ID: 23764467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.